Pan Pingshan, Huang Dongbing, Tang Lu, Yang Zuojian, Qin Guican, Wei Hongwei
Department of Obstetrics, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530000, China.
Department of Obstetrics and Gynecology Ultrasound, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530000, China.
Matern Fetal Med. 2022 Sep 8;4(4):245-250. doi: 10.1097/FM9.0000000000000163. eCollection 2022 Oct.
The aim of the study was to investigate the pregnancy outcomes and possible influencing factors concerning complicated monochorionic (MC) multiple pregnancies undergoing selective fetal reduction using radiofrequency ablation (RFA).
This retrospective cohort study included 54 women with complicated MC multiple pregnancy who underwent selective fetal reduction using RFA at the Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region from January 2015 to March 2020. According to the indications for RFA, the 54 women were divided into three groups: complex complications ( = 30), structural anomalies ( = 18), and triplet pregnancy ( = 6). According to the gestational age for RFA, all patients were divided into three groups: 16-19 weeks ( = 17), 20-23 weeks ( = 17), and 24-26 weeks ( = 20). We analyzed the pregnancy outcomes (including the overall survival rate (OSR), gestational age at delivery, birth weight of newborns) and postoperative complications such as miscarriage, and intrauterine fetal death (IUFD) according to the indications and gestational age of reduction by using suitable statistical testing.
The OSR was 83.3% (45/54). The mean ± standard deviation () of gestation at the time of reduction was 21.6 ± 3.2 weeks. The GA at delivery was 34.0(32.0,37.5) weeks. The mean ± of newborns' birth weight was 2118 ± 685 g. The overall rates of miscarriage, PROM, and IUFD were 9.3% (5/54), 7.4% (4/54), and 7.4% (4/54), respectively. According to the indications for reduction, the OSR for complex complications, structural anomalies, and triplet pregnancy groups were 83.3% (25/30), 83.3% (15/18), and 83.3% (5/6), respectively. Statistically significant differences were only found in the mean birth weight among the three groups ( < 0.05). No significant difference was found in the rate of miscarriage, and mean gestation at delivery among the three groups ( 0.05). In the group with complex complications, the OSR of twin-to-twin transfusion syndrome, selective intrauterine growth restriction, twin reversed arterial perfusion sequence, and twin anemia polycythemia sequence were 66.7% (6/9), 93.3% (14/15), 80.0% (4/5), and 100.0% (1/1), respectively, with no significant difference among these groups ( 0.05). According to the gestational age of reduction, the OSRs among the three groups were 82.4% (14/17), 76.5% (13/17), and 90.0% (18/20), respectively, and the rate of miscarriage, IUFD, and mean gestation age at delivery among these groups showed no significant difference ( 0.05).
Selective fetal reduction by RFA is an important treatment method for complicated MC multiple pregnancy, although it may lead to complications like miscarriage, and IUFD. The indication of reduction seems to affect the pregnancy outcome. An optimal treatment plan should be selected according to the patient's conditions in clinical practice.
本研究旨在探讨采用射频消融术(RFA)进行选择性减胎的复杂性单绒毛膜(MC)多胎妊娠的妊娠结局及可能的影响因素。
这项回顾性队列研究纳入了2015年1月至2020年3月在广西壮族自治区妇幼保健院接受RFA选择性减胎的54例复杂性MC多胎妊娠妇女。根据RFA的指征,将这54例妇女分为三组:复杂并发症组(n = 30)、结构异常组(n = 18)和三胎妊娠组(n = 6)。根据RFA时的孕周,将所有患者分为三组:16 - 19周(n = 17)、20 - 23周(n = 17)和24 - 26周(n = 20)。我们使用适当的统计学检验,根据减胎指征和孕周分析妊娠结局(包括总生存率(OSR)、分娩孕周、新生儿出生体重)以及术后并发症,如流产和宫内胎儿死亡(IUFD)。
总生存率为83.3%(45/54)。减胎时的平均孕周±标准差为21.6 ± 3.2周。分娩时的孕周为34.0(32.0,37.5)周。新生儿出生体重的均值±标准差为2118 ± 685 g。流产、胎膜早破和IUFD的总发生率分别为9.3%(5/54)、7.4%(第4/54)和7.4%(4/54)。根据减胎指征,复杂并发症组、结构异常组和三胎妊娠组的总生存率分别为83.3%(25/30)、83.3%(15/18)和83.3%(5/6)。三组间仅在平均出生体重上存在统计学显著差异(P < 0.05)。三组间在流产率和平均分娩孕周方面未发现显著差异(P > 0.05)。在复杂并发症组中,双胎输血综合征、选择性胎儿生长受限、双胎反向动脉灌注序列和双胎贫血 - 红细胞增多症序列的总生存率分别为66.7%(6/9)、93.3%(14/15)、80.0%(4/5)和100.0%(1/1),这些组间无显著差异(P > 0.05)。根据减胎孕周,三组的总生存率分别为82.4%(14/17)、76.5%(13/17)和90.0%(18/20),这些组间的流产率、IUFD率和平均分娩孕周均无显著差异(P > 0.05)。
尽管RFA选择性减胎可能导致流产和IUFD等并发症,但它是复杂性MC多胎妊娠重要的治疗方法。减胎指征似乎会影响妊娠结局。临床实践中应根据患者情况选择最佳治疗方案。